Home Search
cancer - search results
If you're not happy with the results, please do another search
A digital focus in the fight against skin cancer mortality
Jon Friis, Founder and CEO at Miiskin, states the case for a digital focus in the fight against skin cancer mortality.
Understanding cancer research in the U.S.
Open Access Government lifts the lid on the priorities of the National Cancer Institute, when it comes to cancer research in the U.S.
Western diet rich in red, processed meat linked to colorectal cancer
A Western-style diet rich in red and processed meat, sugar and refined grains and carbohydrates increases risk of colorectal cancer.
Who will pay for the precision cancer medicine revolution?
Ketil Widerberg, General Manager of Oslo Cancer Cluster, describes the complexities of implementing precision cancer medicine in Norway and suggests a way forward.
Ketil Widerberg – Oslo Cancer Cluster
Ketil F. Widerberg, MBA, is General Manager of Oslo Cancer Cluster and Chairman of Oslo Cancer Cluster Incubator
Widerberg builds on a long experience in realising new projects within oncology in the biopharmaceutical company Photocure ASA in collaboration with academic institutions and international commercial partners.
Widerberg has broad operational experience ranging...
The impact of new minimally invasive lung cancer diagnosis and treatment
Elize Sturkenboom – van de Wetering, Venture Leader of Lung Oncology at Phillips Healthcare, discusses the diagnosis and treatment of lung cancer through new minimally invasive therapy.
A new generation of testing for cancer: tools for navigating data in clinical decision...
Utilising early cancer detection: Are we getting the most out of first order tests for symptomatic cancer patients?
Beating lung cancer with the AI edge
Prashant Warier, CEO and Founder, Qure.ai, explains beating lung cancer with the AI edge.
Using AI to deliver high quality, personalised breast cancer screening
Ralph Highnam, PhD, Chief Science & Innovation Officer at Volpara Health, looks at the future of breast cancer screening and the use of AI.
Digital cytology and the future of cervical cancer screening
Cervical cancer is a disease affecting thousands of women in the UK with around 3,200 new cases diagnosed every year, can developments in cervical screening and digital cytology help?
Reducing medical costs of patients with thyroid cancer by centralising medical functions
Professor Hiroki Konno at Nihon University explores proposals for reducing medical costs for patients with thyroid cancer in Japan.
Is there a racial disparity in cancer screenings across England?
According to new research black people are 38% less likely than white people to be diagnosed at cancer screenings in England.
Genomic instability and nuclear architecture in cancer
Sabine Mai and Aline Rangel-Pozzo, at the CancerCare Manitoba Research Institute and The University of Manitoba, Winnipeg, Canada, discuss genomic instability in relation to 3D spatial organization of telomeres.
11 years on: Cancer patients sue operator for Fukushima disaster
Tokyo court hearings are underway for almost $5 million in damages, for six individuals who developed thyroid cancer as a result of the Fukushima disaster.
Part 3: Scientific sunburn & skin cancer
Chanda Siddoo-Atwal, President and Primary Biochemist of Moondust Cosmetics Ltd. continues her discussion on sunburn & skin cancer science.
Racial disparities found in early-onset colon cancer survival rates
Between 1992 and 2013, survival rates for young adults with colorectal cancer (CRC) only improved for Caucasian patients – no increase was seen for those from Black, Hispanic or Asian communities
Banning indoor tanning beds would prevent skin cancer
Banning commercially available indoor tanning beds would prevent skin cancer and reduce deaths from the most serious form of skin cancer known as melanoma.
Former cancer patients not more likely to die from COVID
A study finds that former cancer patients are not more likely to die from COVID than non-cancer patients, if they aren't having active treatment.
Individualised Multimodal Immunotherapy beyond personalised medicine for brain cancer
Stefaan Van Gool, MD, PhD brings to light the important role of Individualised Multimodal Immunotherapy in improving the survival of brain cancer.
Fighting against a Covid tide to deliver cancer referral innovation
PinPoint Data Science is working with the NHS to deliver much needed innovation in cancer referral pathways